Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Future Oncology (London, England)
|
February 19, 2013
Towards personalized therapy for patients with malignant melanoma: molecular insights into the biology of BRAF mutations
Joshua R Bradish, Rodolfo Montironi, Antonio Lopez-Beltran, et al.
Archives of Pathology & Laboratory Medicine
|
May 20, 2016
Utilization of Cell-Transfer Technique for Molecular Testing on Hematoxylin-Eosin-Stained Sections: A Viable Option for Small Biopsies That Lack Tumor Tissues in Paraffin Block
Howard H Wu, Stephen M Jovonovich, Melissa Randolph, et al.
Acta Cytologica
|
November 1, 2014
Detection of BRAF mutation in metastatic melanoma utilizing cell-transferred cytological smears
Shaoxiong Chen, Melissa Randolph, Harvey M Cramer, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
March 12, 2014
Performance evaluation comparison of 3 commercially available PCR-based KRAS mutation testing platforms
Julia A Adams, Kristin M Post, Sarah A Bilbo, et al.
American Journal of Clinical Pathology
|
March 18, 2015
Detection of BRAF mutations on direct smears of thyroid fine-needle aspirates through cell transfer technique
Qiuying Shi, Ashley Ibrahim, Kristi Herbert, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 17, 2013
Utilization of cell-transferred cytologic smears in detection of EGFR and KRAS mutation on adenocarcinoma of lung
Howard H Wu, Joseph P Eaton, Kelly J Jones, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 8, 2014
Discordancy in BRAF mutations among primary and metastatic melanoma lesions: clinical implications for targeted therapy
Joshua R Bradish, Justin D Richey, Kristin M Post, et al.
Histopathology
|
July 19, 2012
KRAS mutation is present in a small subset of primary urinary bladder adenocarcinomas
Riley E Alexander, Antonio Lopez-Beltran, Rodolfo Montironi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 27, 2013
EGFR alterations and EML4-ALK rearrangement in primary adenocarcinoma of the urinary bladder
Riley E Alexander, Rodolfo Montironi, Antonio Lopez-Beltran, et al.
Oncotarget
|
September 15, 2017
Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation
Anna Caliò, John N Eble, Ondrej Hes, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Future Oncology (London, England)
|
February 19, 2013
Towards personalized therapy for patients with malignant melanoma: molecular insights into the biology of BRAF mutations
Joshua R Bradish, Rodolfo Montironi, Antonio Lopez-Beltran, et al.
Archives of Pathology & Laboratory Medicine
|
May 20, 2016
Utilization of Cell-Transfer Technique for Molecular Testing on Hematoxylin-Eosin-Stained Sections: A Viable Option for Small Biopsies That Lack Tumor Tissues in Paraffin Block
Howard H Wu, Stephen M Jovonovich, Melissa Randolph, et al.
Acta Cytologica
|
November 1, 2014
Detection of BRAF mutation in metastatic melanoma utilizing cell-transferred cytological smears
Shaoxiong Chen, Melissa Randolph, Harvey M Cramer, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
March 12, 2014
Performance evaluation comparison of 3 commercially available PCR-based KRAS mutation testing platforms
Julia A Adams, Kristin M Post, Sarah A Bilbo, et al.
American Journal of Clinical Pathology
|
March 18, 2015
Detection of BRAF mutations on direct smears of thyroid fine-needle aspirates through cell transfer technique
Qiuying Shi, Ashley Ibrahim, Kristi Herbert, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 17, 2013
Utilization of cell-transferred cytologic smears in detection of EGFR and KRAS mutation on adenocarcinoma of lung
Howard H Wu, Joseph P Eaton, Kelly J Jones, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 8, 2014
Discordancy in BRAF mutations among primary and metastatic melanoma lesions: clinical implications for targeted therapy
Joshua R Bradish, Justin D Richey, Kristin M Post, et al.
Histopathology
|
July 19, 2012
KRAS mutation is present in a small subset of primary urinary bladder adenocarcinomas
Riley E Alexander, Antonio Lopez-Beltran, Rodolfo Montironi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 27, 2013
EGFR alterations and EML4-ALK rearrangement in primary adenocarcinoma of the urinary bladder
Riley E Alexander, Rodolfo Montironi, Antonio Lopez-Beltran, et al.
Oncotarget
|
September 15, 2017
Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation
Anna Caliò, John N Eble, Ondrej Hes, et al.
Page
of 1